Cargando…
Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer
SIMPLE SUMMARY: The development of specific biomarkers to monitor response to the several available cancer drugs is a major challenge for modern clinical oncology. A reasonable solution for this problem could be to use circulating biomarkers linked to the tumor cell death induced by therapeutic trea...
Autores principales: | Juliachs, Mercè, Pujals, Mireia, Bellio, Chiara, Meo-Evoli, Nathalie, Duran, Juan M., Zamora, Esther, Parés, Mireia, Suñol, Anna, Méndez, Olga, Sánchez-Pla, Alex, Canals, Francesc, Saura, Cristina, Villanueva, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405919/ https://www.ncbi.nlm.nih.gov/pubmed/36010852 http://dx.doi.org/10.3390/cancers14163858 |
Ejemplares similares
-
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells
por: Bellio, Chiara, et al.
Publicado: (2022) -
HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
por: Pujals, Mireia, et al.
Publicado: (2021) -
Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
por: Juliachs, Mercè, et al.
Publicado: (2013) -
E2F1 Regulates Cellular Growth by mTORC1 Signaling
por: Real, Sebastian, et al.
Publicado: (2011) -
Characterization of somatosensory neuron involvement in the SOD1(G93A) mouse model
por: Rubio, Miguel A., et al.
Publicado: (2022)